Aleksandra Bielak
Aleksandra Bielak has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Foryś
Provincial Specialist Hospital No. 5 of St. Barbara in Sosnowiec, Sosnowiec, Poland
5 shared publications - Daria Kuczwalska
Medical University of Warsaw, Warsaw, Poland
5 shared publications - Daria Trocka
St. Adalbert's Hospital Copernicus PL Sp. z o.o., Gdańsk, Poland
5 shared publications - Monika Kałwak
Independent Public Healthcare Facility of the Ministry of Internal Affairs and Administration of Sergeant Grzegorz Załoga in Katowice, Poland
5 shared publications - Antonina Machała4 shared publications
- Maria Spychalska
University Clinical Hospital in Poznan, Przybyszewskiego Str. 49, 60-355 Poznan, Poland
4 shared publications
Latest Publications
- 28 February 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (1)
Polycystic Ovary Syndrome in modern medicine: From etiology to diagnosis and evidence-based management
Background Polycystic ovary syndrome is one of the most common endocrine disorders in women of reproductive age and is associated with reproductive dysfunction, metabolic disturbances, and significant psychological burden. The marked heterogeneity of clinical phenotypes and variability in diagnostic criteria complicate timely diagnosis, risk stratification, and long-term management, underscoring the need for an integrated and clinically oriented synthesis of current evidence. Aims The aim of this narrative review is to summarize and integrate contemporary evidence on the epidemiology, pathophysiology, diagnostic approaches, and management of polycystic ovary syndrome, with particular emphasis on the interrelation of reproductive, metabolic, and psychological aspects relevant to clinical practice. Methods A narrative review of the literature was conducted using the PubMed, Google Scholar, and ResearchGate databases. International clinical guidelines, consensus documents, systematic reviews, meta-analyses, randomized controlled trials, cohort and population-based studies, and clinically relevant review articles were considered. The analysis was descriptive in nature and did not involve a formal systematic review protocol or quantitative data synthesis. Results The reviewed evidence confirms that polycystic ovary syndrome should be regarded as a chronic, multisystem condition rather than a disorder limited to reproductive age. Insulin resistance, hormonal dysregulation, and metabolic abnormalities contribute to long term risks, including infertility, type 2 diabetes mellitus, cardiovascular disease, endometrial pathology, and impaired quality of life. Phenotypic heterogeneity and inconsistent application of diagnostic criteria remain major barriers to early diagnosis and individualized management. Lifestyle modification represents the cornerstone of therapy across phenotypes, while pharmacological and fertility directed interventions should be tailored to individual clinical profiles. Psychological comorbidities are common and frequently underrecognized. Conclusions Effective management of polycystic ovary syndrome requires a patient centred and multidisciplinary approach that integrates reproductive, metabolic, and psychological care. Early identification of metabolic risk factors, long term follow up, and systematic attention to mental health are essential to improve clinical outcomes and quality of life.
- 28 February 2026
- Published by European Scientific Society in Archiv Euromedica
- Vol. 16 (1)
Polycystic Ovary Syndrome in modern medicine: From etiology to diagnosis and evidence-based management
Background Polycystic ovary syndrome is one of the most common endocrine disorders in women of reproductive age and is associated with reproductive dysfunction, metabolic disturbances, and significant psychological burden. The marked heterogeneity of clinical phenotypes and variability in diagnostic criteria complicate timely diagnosis, risk stratification, and long-term management, underscoring the need for an integrated and clinically oriented synthesis of current evidence. Aims The aim of this narrative review is to summarize and integrate contemporary evidence on the epidemiology, pathophysiology, diagnostic approaches, and management of polycystic ovary syndrome, with particular emphasis on the interrelation of reproductive, metabolic, and psychological aspects relevant to clinical practice. Methods A narrative review of the literature was conducted using the PubMed, Google Scholar, and ResearchGate databases. International clinical guidelines, consensus documents, systematic reviews, meta-analyses, randomized controlled trials, cohort and population-based studies, and clinically relevant review articles were considered. The analysis was descriptive in nature and did not involve a formal systematic review protocol or quantitative data synthesis. Results The reviewed evidence confirms that polycystic ovary syndrome should be regarded as a chronic, multisystem condition rather than a disorder limited to reproductive age. Insulin resistance, hormonal dysregulation, and metabolic abnormalities contribute to long term risks, including infertility, type 2 diabetes mellitus, cardiovascular disease, endometrial pathology, and impaired quality of life. Phenotypic heterogeneity and inconsistent application of diagnostic criteria remain major barriers to early diagnosis and individualized management. Lifestyle modification represents the cornerstone of therapy across phenotypes, while pharmacological and fertility directed interventions should be tailored to individual clinical profiles. Psychological comorbidities are common and frequently underrecognized. Conclusions Effective management of polycystic ovary syndrome requires a patient centred and multidisciplinary approach that integrates reproductive, metabolic, and psychological care. Early identification of metabolic risk factors, long term follow up, and systematic attention to mental health are essential to improve clinical outcomes and quality of life.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
KETAMINE IN PAIN MANAGEMENT AND PSYCHIATRIC TREATMENT: CURRENT KNOWLEDGE AND IMPLICATIONS FOR CLINICAL PRACTICE
Research objectives: Ketamine, a derivative of phencyclidine, is a dissociative anesthetic that is used not only in anesthesia but also in analgesic and psychiatric settings such as perioperative and chronic pain, opioid-induced hyperalgesia and treatment-resistant depression management. With the general population’s prevalence of 2-40% for chronic pain and similar lifetime values for depression, ketamine deserves attention as an alternative to commonly used treatments. This research describes the use of subanesthetic ( 0,3 mg/kg to 0,5 mg/kg) ketamine doses in pain management and psychiatric settings, discusses its safety concerning psychomimetic and physical adverse effects and dependence risk, and suggests future research directions. Methods: Review of literature including peer-reviewed studies, meta-analyses, randomized controlled trials, clinical guidelines, focusing on ketamine pharmacokinetics, anesthetic and antidepressant effects, safety and clinical applications. Findings: Ketamine produces satisfactory short-term pain alleviation and rapid antidepressant action. It is part of multimodal anesthesia protocols as an adjuvant to other local anesthetics, prolonging their effects, and is a safe alternative for analgesia in opioid-tolerant patients. It has many routes of administration, which is used in patients with difficult intravenous access in emergencies. It provides a beneficial respiratory effect, alleviates chronic neuropathic and cancer pain, offers rapid response in acute depression including suicidal ideation, prevents post-operative depression risk and supports neuroplasticity. Conclusions: Ketamine is a promising drug in anesthesiology and psychiatry, but its long-term safety is not yet determined. Future research should focus on identifying biomarkers that determine treatment response, optimizing dosage, and discovering safer derivatives.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessKETAMINE IN PAIN MANAGEMENT AND PSYCHIATRIC TREATMENT: CURRENT KNOWLEDGE AND IMPLICATIONS FOR CLINICAL PRACTICE
Research objectives: Ketamine, a derivative of phencyclidine, is a dissociative anesthetic that is used not only in anesthesia but also in analgesic and psychiatric settings such as perioperative and chronic pain, opioid-induced hyperalgesia and treatment-resistant depression management. With the general population’s prevalence of 2-40% for chronic pain and similar lifetime values for depression, ketamine deserves attention as an alternative to commonly used treatments. This research describes the use of subanesthetic ( 0,3 mg/kg to 0,5 mg/kg) ketamine doses in pain management and psychiatric settings, discusses its safety concerning psychomimetic and physical adverse effects and dependence risk, and suggests future research directions. Methods: Review of literature including peer-reviewed studies, meta-analyses, randomized controlled trials, clinical guidelines, focusing on ketamine pharmacokinetics, anesthetic and antidepressant effects, safety and clinical applications. Findings: Ketamine produces satisfactory short-term pain alleviation and rapid antidepressant action. It is part of multimodal anesthesia protocols as an adjuvant to other local anesthetics, prolonging their effects, and is a safe alternative for analgesia in opioid-tolerant patients. It has many routes of administration, which is used in patients with difficult intravenous access in emergencies. It provides a beneficial respiratory effect, alleviates chronic neuropathic and cancer pain, offers rapid response in acute depression including suicidal ideation, prevents post-operative depression risk and supports neuroplasticity. Conclusions: Ketamine is a promising drug in anesthesiology and psychiatry, but its long-term safety is not yet determined. Future research should focus on identifying biomarkers that determine treatment response, optimizing dosage, and discovering safer derivatives.
- Open Access
- 2 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Ocular Rosacea: Beyond the Skin
Background: To the development of rosace contribute factors such as genetic, environmental, and neurovascular causes.. The ocular form affects an estimated prevalence of 10-46% of patients. Symptoms may include redness and tearing of the eyes, foreign body sensation, burning, dryness, itching, photophobia, blurred vision, eyelid margin telangiectasia, and periorbital erythema. Purpose: Ocular rosacea is a long lasting condition that causes persistent inflammation of the eyes and eyelids. The aim of this paper is to organize information on the etiopathogenesis, diagnosis and treatment of this disease. Methods: Comprehensive review of the literature available on PubMed, Google Scholar, Scopus database by searching the keywords “rosacea”, “ocular rosacea”, “ ocular rosacea treatment”, “keratitis”, “dry eye syndroms” Results: Diagnosis requires vigilance because the disease is often confused with other ophthalmological conditions. There are no specific treatment guidelines for ocular rosacea. Managment options depend on the stage of the disease, ranging from conservative treatment based on proper eyelid hygiene and avoidance of triggers in the mildest cases to long-term systemic antibiotic therapy in patients with advanced disease. Conclusions: Ocular rosacea is a disease that is not yet fully understood. Expanding research on this manifestation of rosacea is essential to develop standards for diagnosis and treatment. Collaboration between physicians from multiple specialties in patient care is essential to ensure rapid diagnosis and comprehensive treatment.
- 2 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessOcular Rosacea: Beyond the Skin
Background: To the development of rosace contribute factors such as genetic, environmental, and neurovascular causes.. The ocular form affects an estimated prevalence of 10-46% of patients. Symptoms may include redness and tearing of the eyes, foreign body sensation, burning, dryness, itching, photophobia, blurred vision, eyelid margin telangiectasia, and periorbital erythema. Purpose: Ocular rosacea is a long lasting condition that causes persistent inflammation of the eyes and eyelids. The aim of this paper is to organize information on the etiopathogenesis, diagnosis and treatment of this disease. Methods: Comprehensive review of the literature available on PubMed, Google Scholar, Scopus database by searching the keywords “rosacea”, “ocular rosacea”, “ ocular rosacea treatment”, “keratitis”, “dry eye syndroms” Results: Diagnosis requires vigilance because the disease is often confused with other ophthalmological conditions. There are no specific treatment guidelines for ocular rosacea. Managment options depend on the stage of the disease, ranging from conservative treatment based on proper eyelid hygiene and avoidance of triggers in the mildest cases to long-term systemic antibiotic therapy in patients with advanced disease. Conclusions: Ocular rosacea is a disease that is not yet fully understood. Expanding research on this manifestation of rosacea is essential to develop standards for diagnosis and treatment. Collaboration between physicians from multiple specialties in patient care is essential to ensure rapid diagnosis and comprehensive treatment.
- Open Access
- 2 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Ocular Rosacea: Beyond the Skin
Background: To the development of rosace contribute factors such as genetic, environmental, and neurovascular causes.. The ocular form affects an estimated prevalence of 10-46% of patients. Symptoms may include redness and tearing of the eyes, foreign body sensation, burning, dryness, itching, photophobia, blurred vision, eyelid margin telangiectasia, and periorbital erythema. Purpose: Ocular rosacea is a long lasting condition that causes persistent inflammation of the eyes and eyelids. The aim of this paper is to organize information on the etiopathogenesis, diagnosis and treatment of this disease. Methods: Comprehensive review of the literature available on PubMed, Google Scholar, Scopus database by searching the keywords “rosacea”, “ocular rosacea”, “ ocular rosacea treatment”, “keratitis”, “dry eye syndroms” Results: Diagnosis requires vigilance because the disease is often confused with other ophthalmological conditions. There are no specific treatment guidelines for ocular rosacea. Managment options depend on the stage of the disease, ranging from conservative treatment based on proper eyelid hygiene and avoidance of triggers in the mildest cases to long-term systemic antibiotic therapy in patients with advanced disease. Conclusions: Ocular rosacea is a disease that is not yet fully understood. Expanding research on this manifestation of rosacea is essential to develop standards for diagnosis and treatment. Collaboration between physicians from multiple specialties in patient care is essential to ensure rapid diagnosis and comprehensive treatment.
- 2 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49
Open AccessOcular Rosacea: Beyond the Skin
Background: To the development of rosace contribute factors such as genetic, environmental, and neurovascular causes.. The ocular form affects an estimated prevalence of 10-46% of patients. Symptoms may include redness and tearing of the eyes, foreign body sensation, burning, dryness, itching, photophobia, blurred vision, eyelid margin telangiectasia, and periorbital erythema. Purpose: Ocular rosacea is a long lasting condition that causes persistent inflammation of the eyes and eyelids. The aim of this paper is to organize information on the etiopathogenesis, diagnosis and treatment of this disease. Methods: Comprehensive review of the literature available on PubMed, Google Scholar, Scopus database by searching the keywords “rosacea”, “ocular rosacea”, “ ocular rosacea treatment”, “keratitis”, “dry eye syndroms” Results: Diagnosis requires vigilance because the disease is often confused with other ophthalmological conditions. There are no specific treatment guidelines for ocular rosacea. Managment options depend on the stage of the disease, ranging from conservative treatment based on proper eyelid hygiene and avoidance of triggers in the mildest cases to long-term systemic antibiotic therapy in patients with advanced disease. Conclusions: Ocular rosacea is a disease that is not yet fully understood. Expanding research on this manifestation of rosacea is essential to develop standards for diagnosis and treatment. Collaboration between physicians from multiple specialties in patient care is essential to ensure rapid diagnosis and comprehensive treatment.
- Open Access
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (4(48))
ISCHEMIC STROKE IN YOUNG ADULTS: A MODERN OVERVIEW
The incidence of ischemic stroke in young adults (typically defined as population under 50 years of age) is rising measurably in recent years, an estimated 10-14% of strokes worldwide. It brings severe implications for global public health and economic productivity. This review provides a comprehensive analysis of evidence regarding the changing epidemiology, heterogeneous etiology and long-term outcomes of stroke in the young age. In opposition to older people, where atherosclerosis is one of the most common causes, among young adults there’s a wider variety of risk factors including cervical artery dissection, diverse heart defects, genetic blood clotting disorders and autoimmune diseases. However in a significant number of cases, the cause is difficult to diagnose and often requires advanced diagnosis beyond standard protocols. Modern lifestyle habits, such as obesity, hypertension and substance abuse are responsible for escalating stroke rates. The findings might prove themselves useful in establishing specialized care models for young adults' stroke.
- 24 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (4(48))
Open AccessISCHEMIC STROKE IN YOUNG ADULTS: A MODERN OVERVIEW
The incidence of ischemic stroke in young adults (typically defined as population under 50 years of age) is rising measurably in recent years, an estimated 10-14% of strokes worldwide. It brings severe implications for global public health and economic productivity. This review provides a comprehensive analysis of evidence regarding the changing epidemiology, heterogeneous etiology and long-term outcomes of stroke in the young age. In opposition to older people, where atherosclerosis is one of the most common causes, among young adults there’s a wider variety of risk factors including cervical artery dissection, diverse heart defects, genetic blood clotting disorders and autoimmune diseases. However in a significant number of cases, the cause is difficult to diagnose and often requires advanced diagnosis beyond standard protocols. Modern lifestyle habits, such as obesity, hypertension and substance abuse are responsible for escalating stroke rates. The findings might prove themselves useful in establishing specialized care models for young adults' stroke.